These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23460283

  • 21. Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
    Del Mauro JS, Prince PD, Allo MA, Santander Plantamura Y, Morettón MA, González GE, Bertera FM, Carranza A, Gorzalczany SB, Chiappetta DA, Morales C, Gelpi RJ, Taira CA, Polizio AH, Donato M, Höcht C.
    J Hypertens; 2020 Mar; 38(3):536-545. PubMed ID: 32028517
    [Abstract] [Full Text] [Related]

  • 22. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
    Toblli JE, Cao G, Casas G, Mazza ON.
    Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
    [Abstract] [Full Text] [Related]

  • 23. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
    Pires MJ, Rodríguez-Peña AB, Arévalo M, Cenador B, Evangelista S, Esteller A, Sánchez-Rodríguez A, Colaço A, López-Novoa JM.
    J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
    [Abstract] [Full Text] [Related]

  • 24. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
    Bertera FM, Del Mauro JS, Lovera V, Chiappetta D, Polizio AH, Taira CA, Höcht C.
    Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J, Cobo C, Geukens H, Verhaegen H.
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological properties of nebivolol in man.
    Van Bortel LM, de Hoon JN, Kool MJ, Wijnen JA, Vertommen CI, Van Nueten LG.
    Eur J Clin Pharmacol; 1997 Feb; 51(5):379-84. PubMed ID: 9049578
    [Abstract] [Full Text] [Related]

  • 27. Nebivolol increases arterial distensibility in vivo.
    McEniery CM, Schmitt M, Qasem A, Webb DJ, Avolio AP, Wilkinson IB, Cockcroft JR.
    Hypertension; 2004 Sep; 44(3):305-10. PubMed ID: 15262912
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.
    Del Mauro JS, Prince PD, Santander Plantamura Y, Allo MA, Parola L, Fernandez Machulsky N, Morettón MA, Bin EP, González GE, Bertera FM, Carranza A, Berg G, Taira CA, Donato M, Chiappetta DA, Polizio AH, Höcht C.
    Hypertens Res; 2021 Jul; 44(7):791-802. PubMed ID: 33612826
    [Abstract] [Full Text] [Related]

  • 31. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mülsch A, Li H, Förstermann U, Münzel T.
    Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
    Wang Y, Zhang F, Liu Y, Yin S, Pang X, Li Z, Wei Z.
    Clin Exp Hypertens; 2017 Oct; 39(7):628-639. PubMed ID: 28640644
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive rats.
    Susic D, Fares H, Frohlich ED.
    J Am Soc Hypertens; 2012 Oct; 6(5):316-23. PubMed ID: 22995800
    [Abstract] [Full Text] [Related]

  • 36. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation.
    Kubli S, Feihl F, Waeber B.
    Clin Pharmacol Ther; 2001 Apr; 69(4):238-44. PubMed ID: 11309552
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.